Page 28 - MI-1-1
P. 28
Microbes & Immunity RANTES/CCL5 and ezrin peptide RepG3 for long COVID
31. Islam M, Kalita T, Saikia AK, et al. Significance of RANTES- 42. Monath TP. Treatment of yellow fever. Antiviral Res.
CCR5 axis and linked downstream immunomodulation in 2008;78:116-124.
Dengue pathogenesis: A study from Guwahati, India. J Med doi: 10.1016/j.antiviral.2007.10.009
Virol. 2019;91(12):2066-2073.
43. Sakthivel SK, Singh UP, Singh S, Taub DD, Igietseme JU,
doi: 10.1002/jmv.25561
Lillard JW Jr. CCL5 regulation of mucosal chlamydial
32. Duma L, Häussinger D, Rogowski M, Lusso P, Grzesiek S. immunity and infection. BMC Microbiol. 2008;8:136.
Recognition of RANTES by extracellular parts of the CCR5 doi: 10.1186/1471-2180 8-136
receptor. J Mol Biol. 2007;365(4):1063-1075.
44. Singh R, Singh S, Briles DE, Taub DD, Hollingshead SK,
doi: 10.1016/j.jmb.2006.10.040
Lillard JW Jr. CCL5-independent helper T lymphocyte
33. Coenen M, Nattermann J. The role of CCR5 in HCV responses to immuno-dominant pneumococcal surface
infection. Eur J Med Res. 2010;15:97-101. protein A epitopes. Vaccine. 2012;30(6):1181-1190.
doi: 10.1186/2047-783X-15-3-97 doi: 10.1016/j.vaccine.2011.12.020
34. Thio CL, Astemborski J, Thomas R, et al. Interaction between 45. Vesosky B, Rottinghaus EK, Stromberg P, Turner J, Beamer G.
RANTES promoter variant and CCR5Delta32 favors recovery CCL5 participates in early protection against Mycobacterium
from hepatitis B. J Immunol. 2008;181:7944-7947. tuberculosis. J Leukoc Biol. 2010;87(6):1153-1165.
doi: 10.4049/jimmunol.181.11.7944 doi: 10.1189/jlb.1109742
35. Elliott MB, Tebbey PW, Pryharski KS, Scheuer CA, Laughlin 46. Richardson JP, Moyes DL. Adaptive immune responses to
TS, Hancock GE. Inhibition of respiratory syncytial virus Candida albicans infection. Virulence. 2015;6(4):327-337.
infection with the CC chemokine RANTES (CCL5). J Med doi: 10.1080/21505594.2015.1004977
Virol. 2004;73(2):300-308.
47. Huang C, Levitz SM. Stimulation of macrophage inflammatory
doi: 10.1002/jmv.20091
protein-1a, macrophage inflammatory protein-1b, and
36. Silva T, Temerozo JR, do Vale G, et al. The chemokine RANTES by Candida albicans and Cryptococcus neoformans
CCL5 inhibits the replication of influenza A virus through in peripheral blood mononuclear cells from persons with
SAMHD1 modulation. Front Cell Infect Microbiol. and without human immunodeficiency virus infection.
2021;11:549020. J Infect Dis. 2000;181:791-794.
doi: 10.3389/fcimb.2021.549020 doi: 10.1086/315250
37. Marques RE, Guabiraba R, Del Sarto JL, et al. Dengue virus 48. Govender Y, Chan T, Yamamoto HS, Budnik B, Fichorova
requires the CC-chemokine receptor CCR5 for replication RN. The role of small extracellular vesicles in viral-
and infection development. Immunology. 2015;145:583-596. protozoan symbiosis: Lessons from trichomonasvirus in
an isogenic host parasite model. Front Cell Infect Microbiol.
doi: 10.1111/imm.12476
2020;10:591172.
38. de-Oliveira-Pinto LM, Marinho CF, Povoa TF, et al.
Regulation of inflammatory chemokine receptors on blood doi: 10.3389/fcimb.2020.591172
T cells associated to the circulating versus liver chemokines 49. Murphy PM. The molecular biology of leukocyte chemoattractant
in dengue fever. PLoS One. 2012;7:e38527. receptors. Annu Rev Immunol. 1994;12:593-633.
doi: 10.1371/journal.pone.0038527 doi: 10.1146/annurev.iy.12.040194.003113
39. Wuest TR, Carr DJ. The role of chemokines during herpes 50. Mueller A, Strange PG. Mechanisms of internalization and
simplex virus-1 infection. Front Biosci. 2008;13:4862-4872. recycling of the chemokine receptor, CCR5. Eur J Biochem.
2004;271:243-252.
doi: 10.2741/3045
doi: 10.1046/j.1432-1033.2003.03918.x
40. Vilela MC, Lima GK, Rodrigues DH, et al. Absence of
CCR5 increases neutrophil recruitment in severe herpetic 51. Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M,
encephalitis. BMC Neurosci. 2013;14:19. Sedighi G, Bahar M. The role of JAK-STAT signaling
pathway and its regulators in the fate of T helper cells. Cell
doi: 10.1186/1471-2202-14-19
Commun Signal. 2017;15:23.
41. Karim R, Tummers B, Meyers C, et al. Human papillomavirus
(HPV) upregulates the cellular deubiquitinase UCHL1 to doi: 10.1186/s12964-017-0177-y
suppress the keratinocyte’s innate immune response. PLoS 52. Wong M, Fish EN. RANTES and MIP-1a activate stats in T
Pathog. 2013;9(5)e1003384. cells. J Biol Chem. 1998;273(1):309-314.
doi: 10.1371/journal.ppat.1003384 doi: 10.1074/jbc.273.1.309
Volume 1 Issue 1 (2024) 22 doi: 10.36922/mi.2474

